Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Felicia Dr Rosenthal"'
Autor:
Albrecht Lindemann, I. Hentrich, Andreas Mackensen, Michael Lahn, Felicia Dr Rosenthal, Hendrik Veelken, Regina Kunzmann, Peter Kulmburg, David N. Iklé, Heike Jesuiter, Gabriele Köhler
Publikováno v:
Scopus-Elsevier
We compared the cytogenetic pattern of 20 different primary tumor cell cultures (PTCC) of renal cell carcinoma (RCC) to their cytokine secretion and oncogene expression. High secretion of IL-6 (gene locus on chromosome 7p21-p14) was correlated with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c008663c4d6d05bad120cc04dc7f4a88
https://pubmed.ncbi.nlm.nih.gov/9260606
https://pubmed.ncbi.nlm.nih.gov/9260606
Autor:
Peter Kulmburg, Andreas Mackensen, Michael Lahn, Albrecht Lindemann, Gabriele Köhler, U. Brennscheidt, Brigitte Franke, Felicia Dr Rosenthal, Daniel Becker, Sebastian Wittnebel, Roland Mertelsmann, Hendrik Veelken
Publikováno v:
Journal of molecular medicine (Berlin, Germany). 75(4)
In a phase I trial designed to study a vaccine composed of autologous tumor cells and interleukin-2 gene transfected fibroblasts we analyzed lymphocytes infiltrating the vaccination site (VIL) in two melanoma patients. Functional studies demonstrated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1d80091b5d5f492fadb6e878adea04b
https://pubmed.ncbi.nlm.nih.gov/9151215
https://pubmed.ncbi.nlm.nih.gov/9151215
Autor:
François Herrmann, K. Höffken, G. Küsters, Albrecht Lindemann, H. G. Fuhr, Felicia Dr Rosenthal, Karin Kolbe, R H Mertelsmann
Publikováno v:
New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia ISBN: 9783540526131
Nineteen patients with relapsed or refractory acute myelogenous leukemia were treated with escalating doses of aclacinomycin (ACLA 20–30 mg/m2 daily for 5 days) and intermediate-dose cytosine arabinoside (Ara-C 1 g/m2 twice daily for 4 days). Most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e73721b7c2cbf9cf855f57dde40cb45d
https://doi.org/10.1007/978-3-642-75720-4_2
https://doi.org/10.1007/978-3-642-75720-4_2
